Work

Takotsubo Syndrome: A Contemporary Review of Pathophysiology, Management, Controversies, and Emerging Directions

Year: 2026
Type: article
Abstract: Purpose of Review Once considered benign and self-limiting, Takotsubo syndrome (TTS) is now recognized as an acute cardiac syndrome associated with substantial in-hospital and long-term morbidity and mortality. This review synthesizes contemporary advances in TTS pathophysiology, management, outcomes, and ongoing controversies, with an emphasis on the emerging mechanistic and therapeutic landscape. Recent Findings Our mechanistic understanding of TTS has been recently refined by invasive and noninvasive studies associating coronary microvasculature functionality with disease onset and recovery, neuroimaging implicating heightened amygdala activity and altered limbic connectivity as predisposing neurobiological features, and cardiac and serologic inflammatory markers suggesting both upstream and downstream pathologic influences from immune activation. Contemporary registry data suggest that inpatient mortality and long-term outcomes in TTS patients may be comparable to those in ACS. Furthermore, small case-control data suggest that more than 80% of survivors report persistent symptoms. Data on aspirin and statin use in the absence of CAD suggest limited benefit, while β-blocker and RAASi signals remain discordant across modern registries. The first mechanism-targeted randomized trials, including BROKEN-SWEDEHEART (adenosine/dipyridamole and apixaban), CIT (cyclosporine A), and BREAKOUT (CBT and structured exercise), are now reporting or recruiting, and will provide much-needed evidence to guide future management. Summary TTS is a complex, multifactorial acute cardiac syndrome with long-term consequences, at an inflection point of mechanistic and therapeutic discovery. In the absence of randomized controlled trial data, management remains individualized and guided by expert statements. Continued international, multidisciplinary collaboration spanning cardiology, neurology, psychiatry, endocrinology, and basic science will be essential to translate emerging insights into meaningful improvements in patient outcomes.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,090
OpenAlex ID: W7235234604
FWCI:
Cites: 89
Cited by:
Related to: 10